GetTopicDetailResponse(id=ce5012695982, topicName=子宮內(nèi)膜去分化癌, introduction=, content=PARP抑制劑 子宮內(nèi)膜去分化癌, image=null, comments=0, allHits=247, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat May 17 13:23:49 CST 2025, time=2025-05-17, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=473114, tagList=[TagDto(tagId=473114, tagName=子宮內(nèi)膜去分化癌)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2265412, encodeId=1b1a22654122f, content=<a href='/topic/show?id=e08113e613e' target=_blank style='color:#2F92EE;'>#PARP抑制劑#</a> <a href='/topic/show?id=ce5012695982' target=_blank style='color:#2F92EE;'>#子宮內(nèi)膜去分化癌#</a>, objectTitle=子宮內(nèi)膜去分化癌的遺傳學和臨床特征有哪些？與HRD/MSI-H有關(guān)，有望獲益PARP抑制劑/免疫治療, objectType=article, longId=877722, objectId=46098e772266, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=46098e772266, replyNumber=0, likeNumber=28, createdTime=2025-05-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=46098e772266, moduleTitle=子宮內(nèi)膜去分化癌的遺傳學和臨床特征有哪些？與HRD/MSI-H有關(guān)，有望獲益PARP抑制劑/免疫治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=46098e772266)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-05-17發(fā)表于上海
